Search Results 21-30 of 35897 for Two-phase

  1. RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

    RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus · Overview.

  2. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

    Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS · More about research at Mayo Clinic.

  3. centers-of-excellence

    Overview Tab Title Description Study type Interventional Study phase 2 Study IDs Study type Interventional Describes the nature of a ...

  4. Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in NMIBC - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Multi-phase Dual Energy for Quantitative and Radiologic Evaluation of Chronic Liver Disease - Mayo Clinic

    The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...

  6. Phase 2 Study of VGT-309 in Lung Cancer - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 - Mayo Clinic

    A gene editing medication is one that changes a targeted gene forever. Participation eligibility. Participant eligibility includes age, gender, type and stage ...

  8. Phase 2 Safety And Efficacy Study Of Tulisokibart (MK-7240/PRA023) In Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) - Mayo Clinic

    Phase 2 Safety And Efficacy Study Of Tulisokibart (MK-7240/PRA023) In Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) ...

  9. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    This is a single-arm Simon II stage design, multicenter study consisting of a screening period, an induction treatment period (2 cycles of blinatumomab), a ...

  10. A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction - Mayo Clinic

    Clinical Trials · A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction · More about research at Mayo Clinic.